October 15, 2007
Prospector
Profile
07.1410
 
Advanced Medical Optics, Inc. NAICS 339112
1700 E. St. Andrew Place Santa Ana, CA 92705 Description Medical Instruments Mfg.
(714) 247-8200 Employees 3800
http://www.amo-inc.com Revenue (mil) 997.5000
  Income (mil) 79.4700
  Assets (mil) 2013.9000
  Liability (mil) 1297.9100
  (for the year ended 2006-12-31)
 
Category: Low Rating
 
Event: Moody's Investors Service downgraded Advanced Medical Optics Inc.'s Convertible Subordinated Notes (to LGD5/80% from LGD5/81%) due 2024 to Caa1 from B3.
 
Intellectual Property: The Company has rights to over 1,270 granted and issued patents and over 1,000 pending patent applications relating to aspects of the technology incorporated in many of its products. The Company owns or has rights to material trademarks or trade names used in conjunction with the sale of its products, which include Advanced Medical Optics® , Amadeus™, AMO®, Baerveldt®, blink™, Blink-n-Clean®, ClariFlex®, Complete® , Complete MoisturePLUS™, Complete Revitalize® ,Consept®, Consept 1 Step™, Custom Vue® , Healon®, Healon5®, Healon GV®, OptiEdge™, Oxysept®, Oxysept 1 Step™, ReZoom®, Sensar®, Sovereign®, Sovereign Compact™, Stabileyes®, Star S4 IR™, Tecnis®, The Unfolder®, UltraCare®, Ultrazyme®, Verisyse™, VISX®, WaveScan®, and WhiteStar®. Amadeus is a trademark of SIS Ltd. [SEC Filing 10-K 03-01-07]
 
Description: The Company develops, manufactures and markets surgical devices for the eyes worldwide.
 
Officers: James V. Mazzo (CEO); Richard A. Meier (COO); Christopher G. Chavez (Dir); Holger Heidrich Ph.D (VP); C. Russell Trenary III, (VP)
 
Auditor: PricewaterhouseCoopers LLP
 
Securities: Common Stock Symbol EYE; NYSE; 60,458,073 common shares outstanding as of July 31, 2007.
 
 
 
return to main page